{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:33Z","timestamp":1786119273228,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/wnf.0b013e3181914d0a","type":"journal-article","created":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T03:54:11Z","timestamp":1248753251000},"page":"213-218","source":"Crossref","is-referenced-by-count":122,"title":["Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A"],"prefix":"10.1097","volume":"32","author":[{"given":"Oliver","family":"Lange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Bigalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"deGroot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wohlfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0733-8635(03)00019-6","article-title":"Development of botulinum toxin therapy.","volume":"22","author":"Scott","year":"2004","journal-title":"Dermatol Clin"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000064953","article-title":"Clinical features of antibody-induced complete secondary failure of botulinum toxin therapy.","volume":"48","author":"Dressler","year":"2002","journal-title":"Eur Neurol"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1097\/00002508-200211001-00004","article-title":"Considering the immune response to botulinum toxin.","volume":"18","author":"Critchfield","year":"2002","journal-title":"Clin J Pain"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1615\/CritRevImmunol.v27.i4.30","article-title":"Molecular bases of protective immune responses against botulinum neurotoxin A-how antitoxin antibodies block its action.","volume":"27","author":"Atassi","year":"2007","journal-title":"Crit Rev Immunol"},{"issue":"suppl 6","key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"vi3","DOI":"10.1093\/ndt\/gfh1092","article-title":"Factors influencing the immunogenicity of therapeutic proteins.","volume":"20","author":"Schellekens","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies-therapeutic consequences.","volume":"147","author":"Goschel","year":"1997","journal-title":"Exp Neurol"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/mds.20625","article-title":"Mouse diaphragm assay for detection of antibodies against botulinum toxin type B.","volume":"20","author":"Dressler","year":"2005","journal-title":"Mov Disord"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00004951","article-title":"Botulinum A toxins: units versus units.","volume":"355","author":"Wohlfarth","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"suppl 8","key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/mds.20021","article-title":"Detection of antibodies against botulinum toxins.","volume":"19","author":"Sesardic","year":"2004","journal-title":"Mov Disord"},{"issue":"suppl 8","key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/mds.20022","article-title":"Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.","volume":"19","author":"Dressler","year":"2004","journal-title":"Mov Disord"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000052139","article-title":"Botulinum toxin antibody testing: comparison between the immunoprecipitation assay and the mouse diaphragm assay.","volume":"45","author":"Dressler","year":"2001","journal-title":"Eur Neurol"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/mds.21051","article-title":"Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test.","volume":"21","author":"Cordivari","year":"2006","journal-title":"Mov Disord"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/014107689208500906","article-title":"Botulinum toxin treatment of spasmodic torticollis.","volume":"85","author":"Anderson","year":"1992","journal-title":"J R Soc Med"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004150050345","article-title":"Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency.","volume":"246","author":"Kessler","year":"1999","journal-title":"J Neurol"},{"key":"R15-7-20210203","first-page":"A82","article-title":"Botulinum toxin A antibodies in initial and delayed resistance to botulinum toxin A therapy in cervical dystonia.","volume":"10","author":"Duane","year":"1995","journal-title":"Mov Disord"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","article-title":"Response and immunoresistance to botulinum toxin injections.","volume":"45","author":"Jankovic","year":"1995","journal-title":"Neurology"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.410290407","article-title":"Change in pattern of muscle activity following botulinum toxin injections for torticollis.","volume":"29","author":"Gelb","year":"1991","journal-title":"Ann Neurol"},{"issue":"pt 4","key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/brain\/121.4.547","article-title":"Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia.","volume":"121","author":"Dauer","year":"1998","journal-title":"Brain"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","article-title":"Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.","volume":"17","author":"Hsiung","year":"2002","journal-title":"Mov Disord"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jclinepi.2005.12.001","article-title":"The nature and power of the placebo effect.","volume":"59","author":"Miller","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.46.1.26","article-title":"Botulinum toxin therapy, immunologic resistance, and problems with available materials.","volume":"46","author":"Borodic","year":"1996","journal-title":"Neurology"},{"issue":"suppl 8","key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/mds.20022","article-title":"Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.","volume":"19","author":"Dressler","year":"2004","journal-title":"Mov Disord"},{"key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.870090216","article-title":"Development of resistance to botulinum toxin type A in patients with torticollis.","volume":"9","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/jnnp.2006.093419","article-title":"New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia.","volume":"78","author":"Dressler","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R25-7-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.iop.0000217703.80859.a3","article-title":"Immunologic resistance after repeated botulinum toxin type A injections for facial rhytides.","volume":"22","author":"Borodic","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R26-7-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/MR.56.1.80-99.1992","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine.","volume":"56","author":"Schantz","year":"1992","journal-title":"Microbiol Rev"},{"issue":"suppl 2","key":"R27-7-20210203","first-page":"R20","article-title":"In vitro stability of botulinum toxin complex preparations at physiological pH and temperature.","author":"Friday","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10659","article-title":"Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.","volume":"19","author":"Haussermann","year":"2004","journal-title":"Mov Disord"},{"key":"R29-7-20210203","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1128\/AEM.58.10.3426-3428.1992","article-title":"Stabilization of botulinum toxin type A during lyophilization.","volume":"58","author":"Goodnough","year":"1992","journal-title":"Appl Environ Microbiol"},{"key":"R30-7-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1353\/pbm.1997.0032","article-title":"Botulinum toxin: the story of its development for the treatment of human disease.","volume":"40","author":"Schantz","year":"1997","journal-title":"Perspect Biol Med"},{"key":"R31-7-20210203","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","article-title":"Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.","volume":"60","author":"Jankovic","year":"2003","journal-title":"Neurology"},{"key":"R32-7-20210203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinthera.2007.04.015","article-title":"Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.","volume":"29","author":"Yablon","year":"2007","journal-title":"Clin Ther"},{"key":"R33-7-20210203","first-page":"176","article-title":"The development of toxin neutralizing antibodies with botulinum toxin type A (BoNTA) treatment.","volume":"20","author":"Yablon","year":"2006","journal-title":"Neurorehabil Neural Repair"},{"key":"R34-7-20210203","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.apmr.2008.01.007","article-title":"Repeated treatments with botulinum toxin type A produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.","volume":"89","author":"Elovic","year":"2008","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181914d0a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:57:07Z","timestamp":1786039027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200907000-00007"}},"subtitle":["Much Ado About Nothing?"],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181914d0a","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}